American Portfolios Advisors Mustang Bio, Inc. Transaction History

American Portfolios Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Mar 22, 2023	BUY	$2.7 - $3.81 $10,179 - $14,363	3,770 New	3,770 $12.5 Million
Q1 2021 Mar 22, 2023	BUY	$3.02 - $5.16 $11,385 - $19,453	3,770 New	3,770 $12.5 Million
Q4 2020 Mar 22, 2023	BUY	$2.66 - $4.18 $10,028 - $15,758	3,770 New	3,770 $14.3 Million
Q3 2020 Mar 22, 2023	BUY	$3.01 - $3.88 $11,347 - $14,627	3,770 New	3,770 $11.9 Million
Q1 2020 Mar 24, 2023	BUY	$1.91 - $4.52 $7,200 - $17,040	3,770 New	3,770 $10.1 Million

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.